摘要
背景:国际癌症研究机构(InternationalAgency For CancerResearch)的最新数据显示,乳腺癌是女性癌症的主要发源地,也是女性癌症的主要死因。活性氧(ROS)的诱导和氧化应激是由于氧化原和抗氧化剂之间的平衡受损而引起的,提示ROS和氧化应激参与了乳腺癌的诱导和发展。与正常细胞相比,癌细胞表现出更高水平的活性氧。然而,抗氧化防御的增加,平衡了癌细胞内的氧化状态,表明高水平的活性氧可能通过各种机制阻止肿瘤的发生。ROS和氧化应激在乳腺癌中的这些相互矛盾的作用使科学家们研究了潜在的氧化应激调节剂作为抗癌策略。结论:本文就乳腺癌细胞ROS产生的机制、氧化损伤状态的作用以及引入氧化应激调节剂在乳腺癌治疗策略中的作用进行了综述。这篇综述更多地集中在褪黑素上,这是我们在过去十年中一直在研究的。根据文献,我们的数据表明褪黑素在乳腺癌预防和辅助治疗中具有重要作用。
关键词: 氧化应激,活性氧,乳腺癌,氧化应激调节剂,褪黑素。
Current Medicinal Chemistry
Title:The Role of Oxidative Stress Modulators in Breast Cancer
Volume: 25 Issue: 33
关键词: 氧化应激,活性氧,乳腺癌,氧化应激调节剂,褪黑素。
摘要: Background: Latest data from International Agency for Cancer Research shows that breast cancer is the leading cancer site in women and is the leading cause of death among female cancers. Induction of reactive oxygen species (ROS) and oxidative stress as a consequence of impaired balance between prooxidants and antioxidants are suggested to be involved in induction and progression of breast cancer. Cancer cells are found to exhibit higher levels of ROS compared to normal cells. However increased antioxidant defence which balances the oxidative status within the cancer cells suggests that high ROS levels may prevent tumorigenesis via various mechanisms. These contradictory roles of ROS and oxidative stress in breast cancer let scientists investigate potential oxidative stress modulators as anticancer strategies.
Conclusions: In the present review we address the mechanisms of ROS production in breast cancer cells, the role of impaired oxidative status as well as the benefits of introducing oxidative stress modulators in therapeutic strategies in breast cancer. This review is focusing more on melatonin which we have been working on during the last decade. Our data, in accordance with the literature, suggest an important role for melatonin in breast cancer prevention and adjuvant therapy.
Export Options
About this article
Cite this article as:
The Role of Oxidative Stress Modulators in Breast Cancer, Current Medicinal Chemistry 2018; 25 (33) . https://dx.doi.org/10.2174/0929867324666170711114336
DOI https://dx.doi.org/10.2174/0929867324666170711114336 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Strategies for the Biological Evaluation of Gold Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Recent Advances in the Treatment of Helicobacter pylori Infection
Recent Patents on Anti-Infective Drug Discovery Imaging Primary Brain Tumors by Single-Photon Emission Computerized Tomography (SPECT) with Technetium-99m Sestamibi (MIBI) and Tetrofosmin
Current Medical Imaging Conjugation of Peptides to Antisense Interleukin-6 Via Click Chemistry
Current Medicinal Chemistry Guggulsterone for Chemoprevention of Cancer
Current Pharmaceutical Design Nanotechnology Advances in Brain Tumors: The State of the Art
Recent Patents on Anti-Cancer Drug Discovery A Promising Anti-Cancer and Anti-Oxidant Agents Based on the Pyrrole and Fused Pyrrole: Synthesis, Docking Studies and Biological Evaluation
Anti-Cancer Agents in Medicinal Chemistry Recent Advancemnts in Biodegradable Ocular Implants
Current Drug Delivery Poor Safety and Tolerability Hamper Reaching a Potentially Therapeutic Dose in the Use of Thalidomide for Alzheimer’s Disease: Results from a Double-Blind, Placebo-Controlled Trial
Current Alzheimer Research Zinc and its Specific Transporters as Potential Targets in Airway Disease
Current Drug Targets Bisthiourea Derivatives of Dipeptide Conjugated Benzo[d]isoxazole as a New Class of Therapeutics: Synthesis and Molecular Docking Studies
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Identification of Cancerlectins By Using Cascade Linear Discriminant Analysis and Optimal g-gap Tripeptide Composition
Current Bioinformatics Estrogen Receptor Alpha: Impact of Ligands on Intracellular Shuttling and Turnover Rate in Breast Cancer Cells
Current Cancer Drug Targets Cancer Stem Cells Switch on Tumor Neovascularization
Current Molecular Medicine Cannabinoids
Current Drug Targets - CNS & Neurological Disorders Human Serum Albumin Conjugated Biomolecules for Cancer Molecular Imaging
Current Pharmaceutical Design Impact of Sex Hormone Metabolism on the Vascular Effects of Menopausal Hormone Therapy in Cardiovascular Disease
Current Drug Metabolism Pleiotropic Actions of PPARg Activators Thiazolidinediones in Cardiovascular Diseases
Current Pharmaceutical Design Inflammatory Mediators in Epilepsy
Current Pharmaceutical Design Therapeutic Challenges in Neuroendocrine Tumors
Anti-Cancer Agents in Medicinal Chemistry